Filing Details

Accession Number:
0001144204-13-030864
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-21 17:46:06
Reporting Period:
2013-05-17
Filing Date:
2013-05-21
Accepted Time:
2013-05-21 17:46:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1523662 Binh Nguyen 3000 Kent Avenue
Suite A1-100
West Lafayette IN 47906
Vp Of Clinical Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-17 17,300 $3.55 17,300 No 4 M Direct
Common Stock Disposition 2013-05-17 17,300 $14.42 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2013-05-17 17,300 $0.00 17,300 $3.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,700 2022-02-28 No 4 M Direct
Footnotes
  1. Shares subject to the option vest annually over a four (4) year period beginning on March 1, 2013.
  2. Represents the sale of 17,300 shares in multiple transactions, ranging in price from $14.41 to $14.4701 per share, resulting in a weighted average sale price per share of $14.42. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.